Skip to main content

Table 1 Expression of HER2 and EGFR in primary tumours of CRC patients with ovarian and non-ovarian metastases

From: Clinical significance of HER2 and EGFR expression in colorectal cancer patients with ovarian metastasis

   Total (n) Expression (n) Positive rate (%) Z P
  (−) (+) (++) (+++)
HER2 Ovarian metastasis 22 4 6 6 6 54.5 −2.004 0.045
Non-ovarian metastasis 22 12 2 5 3 36.4
EGFR Ovarian metastasis 22 1 7 6 8 63.6 −1.055 0.315
Non-ovarian metastasis 24 7 3 7 7 58.3